Amphetamine dependence
Wikipedia on Answers.com:
Top
Amphetamine dependence
| Amphetamine dependence | |
|---|---|
| Classification and external resources | |
 Amphetamine |
|
| ICD-10 | F15.2 |
| ICD-9 | 304.4 |
Amphetamine dependence refers to a state of dependence on a drug in the amphetamine class.
Tolerance is developed rapidly in amphetamine abuse, thereby the amount of the drug that is needed to satisfy the addiction needs to be increased at regular intervals.[1]
Conversely, some researchers have reported observing the opposite effect in animal models: repeated amphetamine use can produce reverse tolerance or sensitization to the psychological or locomotor-stimulating effects of the drug.[2] Development of sensitization to amphetamine may depend on the daily dosage of amphetamine[3] or the amount of time elapsed since the discontinuation of repeated dosing.[4]
In rodent studies, repeated amphetamine treatment produces robust behavioral sensitization (or reverse tolerance) to some of the drug's effects.[5] Depending on the dosing regimen, sensitization may persist for up to one year after the discontinuation of amphetamine treatment in rodents.[6]
In humans, however, there is no systematic evidence of the development of behavioral sensitization to amphetamine after acute or chronic amphetamine treatment when the drug is used in the therapeutic dose range (i.e., is not abused).[7] The absence of observed sensitization development in humans (compared to that observed in rodents) may be explained by different amphetamine metabolism or different mechanisms of action of amphetamine in humans versus rats.[8]
Amphetamine does not have the potential to cause physical dependence, though withdrawal can still be hard for a user.[9][10][11]
Self-directed Management of Amphetamine withdrawal amongst recreational users tends to be quite precarious due to lack of proper medical education and prescribing discipline; examples include users who attempt to postpone the amphetamine "crash" by taking more of the drug, which in fact makes matters worse by making the crash even greater. Users may self-medicate using Anxiolytic (Sedating) medicines to allow themselves to sleep or relax, of which may include sedating anti-histamines (cyproheptadine), benzodiazepines (alprazolam) or opioid medicines (Codeine, oxycodone)
References
- ^ "Amphetamines: Drug Use and Abuse: Merck Manual Home Health Handbook". Merck. Archived from the original on February 17, 2007. http://web.archive.org/web/20070217053619/http://www.merck.com/mmhe/sec07/ch108/ch108g.html. Retrieved February 28, 2007.
- ^ Wolf, Marina; White, Francis; Nassar, Richard; Brooderson, Richard; Khansa, Mohamad (January 1993). "Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization" (PDF). Journal of Pharmacology and Experimental Therapeutics 264 (1): 249–255. ISSN 0022-3565. PMID 8093727. http://jpet.aspetjournals.org/content/264/1/249.full.pdf.
- ^ Hooks, M.; Jones, G.; Neill, D.; Justice Jr., J. (January 1992). "Individual differences in amphetamine sensitization: dose-dependent effects". Pharmacology, Biochemistry, and Behavior 41 (1): 203–210. doi:10.1016/0091-3057(92)90083-R. ISSN 0091-3057. PMID 1539070. http://linkinghub.elsevier.com/retrieve/pii/009130579290083R.
- ^ Paulson, Pamela; Robinson, Terry (January 1995). "Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats" (PDF). Synapse 19 (1): 56–65. doi:10.1002/syn.890190108. ISSN 0887-4476. PMC 1859849. PMID 7709344. http://www3.interscience.wiley.com/cgi-bin/fulltext/109703180/PDFSTART.
- ^ Robinson, Terry; Kolb, Bryan (May 1999). "Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine". European Journal of Neuroscience 11 (5): 1598–1604. doi:10.1046/j.1460-9568.1999.00576.x. ISSN 0953-816X. PMID 10215912. http://www3.interscience.wiley.com/cgi-bin/fulltext/121442612/HTMLSTART.
- ^ Robinson, Terry; Kolb, Bryan (November 1997). "Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine". Journal of Neuroscience 17 (21): 8491–8497. ISSN 0270-6474. PMID 9334421. http://www.jneurosci.org/cgi/content/full/17/21/8491.
- ^ Solanto, Mary (January 2000). "Clinical psychopharmacology of AD/HD: implications for animal models". Neuroscience and Biobehavioral Reviews 24 (1): 27–30. doi:10.1016/S0149-7634(99)00061-5. ISSN 0149-7634. PMID 10654657. http://linkinghub.elsevier.com/retrieve/pii/S0149763499000615.
- ^ Advokat, Claire (July 2007). "Update on amphetamine neurotoxicity and its relevance to the treatment of ADHD" (PDF). Journal of Attention Disorders 11 (1): 8–16. doi:10.1177/1087054706295605. ISSN 1087-0547. PMID 17606768. http://jad.sagepub.com/cgi/reprint/11/1/8.pdf.
- ^ Chronic Amphetamine Use and Abuse
- ^ Sax KW, Strakowski SM (2001). "Behavioral sensitization in humans". J Addict Dis. 20 (3): 55–65. doi:10.1016/0006-3223(95)00497-1. PMID 11681593.
- ^ I. Boileau, A. Dagher, M. Leyton, R. N. Gunn, G. B. Baker, M. Diksic and C. Benkelfat (2006). "Modeling Sensitization to Stimulants in Humans: An [11C]Raclopride/Positron Emission Tomography Study in Healthy Men". Arch Gen Psychiatry 63 (12): 1386–1395. doi:10.1001/archpsyc.63.12.1386. PMID 17146013. http://archpsyc.ama-assn.org/cgi/content/abstract/63/12/1386.
|
||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Post a question - any question - to the WikiAnswers community:
Copyrights:
Wikipedia on Answers.com
This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article Amphetamine dependence.
Read more